Skip to content
Recall Observatory FDA recall evidence

Drug product

Bevacizumab 2.5 mg/0.1 mL, Solution for Injection in 1mL, silicone free slip tip syringe, each Syringe supplied in individually labeled poly envelopes (primary packaging). Repackaged by Pine Pharmaceuticals, Pine Pharmaceuticals 355 Riverwalk Parkway, Tonawanda, NY 14150, Office Use Only, Not for Resale. Secondary packaging consists of a coated cardboard box, with order-specific label indicating lot number housed within order/container. NDC # 69194-0458-1

D-0531-2023

March 27, 2023

Class III

Product summary

Firm
Pine Pharmaceuticals, LLC
Event
Event 91972
Status
Terminated
Classification
Class III
Quantity
932 syringes
Official record key
drug-enforcement:D-0531-2023

Official wording

Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Lot code on primary packaging is incorrect.

Code information: Lot # 66377, Exp. Date: 06/28/2023. Syringe may be labeled incorrectly as lot# 66316

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Incorrect or Missing